Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Unum Therapeutics
One Broadway, 4th Floor
Cambridge, MA 02142
www.unumrx.com

Unum Therapeutics uses proprietary T-cell engineering technology in combination with tumor-targeting antibodies to activate the body's own immune system to fight cancer. Unum's lead program, based on its Antibody-Coupled T-cell Receptor (ACTR) technology, is expected to enter Phase I clinical testing in the coming months to assess safety and efficacy. Unum is seeking partners interested in using the ACTR technology to arm proprietary tumor-specific antibodies with a T-cell to improve their therapeutic potential. The company is headquartered in Cambridge, MA.

Key Contact
Name
Chuck Wilson
Title
CEO
Funding Events

Date
Amount
Type
Investors
Valuation
10/21/14 $12,000,000 Series A Atlas Venture
undisclosed
06/11/15 $65,000,000 Series B Atlas Venture
Brace Pharma
Cowen Private Investments
Jennison Associates
New Leaf Venture Partners
Novo A/S
Sabby Management
Sectoral Asset Management
Wellington Management Company
undisclosed
07/08/20 $104,400,000 Series A Acorn Bioventures
Ally Bridge Group
Atlas Venture
BVF Partners
Commodore Capital
Fairmount Funds Management
Logos Capital
OrbiMed Advisors
Perceptive Advisors
RTW Investments
Samsara BioCapital
Venrock Healthcare Partners
undisclosed